These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37396043)

  • 1. Polygenic risk scores in pharmacogenomics: opportunities and challenges-a mini review.
    Simona A; Song W; Bates DW; Samer CF
    Front Genet; 2023; 14():1217049. PubMed ID: 37396043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applying polygenic risk score methods to pharmacogenomics GWAS: challenges and opportunities.
    Zhai S; Mehrotra DV; Shen J
    Brief Bioinform; 2023 Nov; 25(1):. PubMed ID: 38152980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics polygenic risk score for drug response prediction using PRS-PGx methods.
    Zhai S; Zhang H; Mehrotra DV; Shen J
    Nat Commun; 2022 Sep; 13(1):5278. PubMed ID: 36075892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics polygenic risk score: Ready or not for prime time?
    Singh S; Stocco G; Theken KN; Dickson A; Feng Q; Karnes JH; Mosley JD; El Rouby N
    Clin Transl Sci; 2024 Aug; 17(8):e13893. PubMed ID: 39078255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical considerations in genomic decision support: The eMERGE experience.
    Herr TM; Bielinski SJ; Bottinger E; Brautbar A; Brilliant M; Chute CG; Cobb BL; Denny JC; Hakonarson H; Hartzler AL; Hripcsak G; Kannry J; Kohane IS; Kullo IJ; Lin S; Manzi S; Marsolo K; Overby CL; Pathak J; Peissig P; Pulley J; Ralston J; Rasmussen L; Roden DM; Tromp G; Uphoff T; Weng C; Wolf W; Williams MS; Starren J
    J Pathol Inform; 2015; 6():50. PubMed ID: 26605115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and Opportunities for Developing More Generalizable Polygenic Risk Scores.
    Wang Y; Tsuo K; Kanai M; Neale BM; Martin AR
    Annu Rev Biomed Data Sci; 2022 Aug; 5():293-320. PubMed ID: 35576555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design Recommendations for Pharmacogenomics Clinical Decision Support Systems.
    Khelifi M; Tarczy-Hornoch P; Devine EB; Pratt W
    AMIA Jt Summits Transl Sci Proc; 2017; 2017():237-246. PubMed ID: 28815136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries.
    Blagec K; Swen JJ; Koopmann R; Cheung KC; Crommentuijn-van Rhenen M; Holsappel I; Konta L; Ott S; Steinberger D; Xu H; Cecchin E; Dolžan V; Dávila-Fajardo CL; Patrinos GP; Sunder-Plassmann G; Turner RM; Pirmohamed M; Guchelaar HJ; Samwald M;
    PLoS One; 2022; 17(6):e0268534. PubMed ID: 35675343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of obesity polygenic risk scores from research to clinical practice: A review.
    Jansen PR; Vos N; van Uhm J; Dekkers IA; van der Meer R; Mannens MMAM; van Haelst MM
    Obes Rev; 2024 Nov; 25(11):e13810. PubMed ID: 39075585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization.
    Lewis ACF; Perez EF; Prince AER; Flaxman HR; Gomez L; Brockman DG; Chandler PD; Kerman BJ; Lebo MS; Smoller JW; Weiss ST; Blout Zawatksy CL; Meigs JB; Green RC; Vassy JL; Karlson EW
    Genome Med; 2022 Oct; 14(1):114. PubMed ID: 36207733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a clinical polygenic risk score assay and reporting workflow.
    Hao L; Kraft P; Berriz GF; Hynes ED; Koch C; Korategere V Kumar P; Parpattedar SS; Steeves M; Yu W; Antwi AA; Brunette CA; Danowski M; Gala MK; Green RC; Jones NE; Lewis ACF; Lubitz SA; Natarajan P; Vassy JL; Lebo MS
    Nat Med; 2022 May; 28(5):1006-1013. PubMed ID: 35437332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polygenic risk scores: An overview from bench to bedside for personalised medicine.
    Cross B; Turner R; Pirmohamed M
    Front Genet; 2022; 13():1000667. PubMed ID: 36437929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare.
    Giri J; Moyer AM; Bielinski SJ; Caraballo PJ
    Pharmgenomics Pers Med; 2019; 12():305-318. PubMed ID: 31802928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usability evaluation of pharmacogenomics clinical decision support aids and clinical knowledge resources in a computerized provider order entry system: a mixed methods approach.
    Devine EB; Lee CJ; Overby CL; Abernethy N; McCune J; Smith JW; Tarczy-Hornoch P
    Int J Med Inform; 2014 Jul; 83(7):473-83. PubMed ID: 24874987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer's Disease.
    Vlachakis D; Papakonstantinou E; Sagar R; Bacopoulou F; Exarchos T; Kourouthanassis P; Karyotis V; Vlamos P; Lyketsos C; Avramopoulos D; Mahairaki V
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical genetics and polygenic risk score for precision medicine.
    Konuma T; Okada Y
    Inflamm Regen; 2021 Jun; 41(1):18. PubMed ID: 34140035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic risk score (PRS) and its potential for breast cancer risk stratification.
    Hovhannisyan M; Kleiblová P; Nehasil P; Soukupová J; Zemánková P; Kleibl Z; Janatová M
    Klin Onkol; 2023; 36(3):198-205. PubMed ID: 37353348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing a prototype system for integrating pharmacogenomics findings into clinical practice.
    Overby CL; Tarczy-Hornoch P; Kalet IJ; Thummel KE; Smith JW; Del Fiol G; Fenstermacher D; Devine EB
    J Pers Med; 2012 Nov; 2(4):241-56. PubMed ID: 23741623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Pharmacogenomics Clinical Decision Support Service Based on FHIR and CDS Hooks.
    Dolin RH; Boxwala A; Shalaby J
    Methods Inf Med; 2018 Dec; 57(S 02):e115-e123. PubMed ID: 30605914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.